Company Data

Helix BioPharma Corp.

Fundamental Analysis:

Helix BioPharma Corp.

Helix BioPharma Corp.
Fundamental Analysis:
Ticker
HBP:CA
Current Price
$1.52 -4.4%
Market Cap
$112.7M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$0.5 - $1.6
Advanced Market Data

Overview

Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy